MSCI — MSCI Inc.

The tape is unambiguously positive. The 2026-10-20 print delivered 12.4% revenue growth, 56.3% operating margin and adjusted EPS of $5.11 against ~$5.03 consensus; the stock jumped +6.74% to $601.45, its 1-week return of +6.99% and 1-month return of +8.52% both dwarf the +0.44% six-month return that preceded it. Index segment revenue rose 18.1% to $532.6M with asset-based fees up 24.9% to $249.1M, organic subscription run-rate growth of 8.7% and a 95.0% retention rate. The sell side is constructive (20 Buy/1 Strong Buy vs 6 Hold/1 Sell) but note the wrinkle: consensus target sits at $701.71 while the most recent four targets average $681.75 and JPMorgan/Morgan Stanley trimmed to the $662-$685 area in October 2026 - analysts like the business but are shaving targets, which fits a stock that is re-rating on earnings rather than on multiple expansion.

Revenue growth has genuinely stepped up, not just wobbled. YoY by quarter ran +7.7% (Q4 2024), +9.7% (Q1 2025), +9.1% (Q2 2025), +9.5% (Q3 2025), then jumped to +10.6% (Q4 2025), +14.1% (Q1 2026), +12.2% (Q2 2026) and +12.4% (Q3 2026) - three straight quarters in the low-to-mid teens versus a ~9% run-rate through 2025. Absolute revenue went from $680.0M in Q1 2024 to $892.0M in Q3 2026. Margins confirm operating leverage: TTM operating margin is 55.7% versus 54.2% a year earlier, and the seasonally weak Q1 margin improved from 50.6% (Q1 2025) to 53.7% (Q1 2026), with Q3 roughly flat YoY at 56.3% vs 56.4%. Reported EPS is noisy (Q4 2025's $3.68 and Q1 2026's $5.53 are distorted by tax and below-the-line items) so use the cleaner 14.6% YoY growth in Q3 diluted EPS ($4.86 vs $4.24). The one soft spot: TTM free cash flow grew only 2.1% ($1,507.9M vs $1,477.4M) against 12.3% revenue growth, as Q3 2026 capex spiked to $50.7M from $3.9M a year earlier. That looks like a one-quarter capex step-up plus working capital, not margin erosion - the reported accruals ratio of -1.52% says cash is still running ahead of book income.

Fair, with a real discount to its own history that is less compelling than it looks. As of 2026-10-20 the stock was at 32.0x TTM EPS of $18.80 and ~30.6x the $19.67 forward estimate (PEG 1.68), versus a 5-year average TTM P/E of 46.3x and a 5-year average P/S of 18.0x against 12.7x now - roughly a 30% discount on both metrics. The catch is that the 46x average was inflated by the 2020-21 multiple bubble; paying 31x for a business that grows revenue 12% and EPS mid-teens is reasonable, not cheap. EV/EBITDA of ~24x and $6.5B of net debt against a $43.7B market cap keep this out of bargain territory. My own fair value lands at ~$665, or roughly 10% above the 2026-10-20 close.

The price is tracking earnings that have already arrived rather than discounting a hoped-for turnaround - 12.4% revenue growth and 56% margins are in the reported numbers, and the +6.7% move on 2026-10-20 was an acknowledgement, not a projection. The asymmetry worth watching: the forward EPS estimate of $19.67 implies only ~5% growth over trailing $18.80, which looks too conservative against a $5.11 adjusted Q3 print and 12%+ top-line growth; that sets up upward revisions into the 2027-01-26 report. The offset is that ~$249M of quarterly revenue is asset-based and levered to equity market levels, so in a drawdown earnings and the multiple would compress together. You are being paid for business quality here, not for a mispriced recovery.

As of 2026-10-20, RSI(14) stood at 68.0 - firm but not yet overbought - with the price 7.6% above its 20-day SMA (~$559), 7.25% above its 50-day SMA (~$561) and 4.8% above its 200-day SMA (~$574). That is a textbook post-earnings breakout from a six-month flat base (six-month return of just +0.44%), and the trend read is constructive. Entry timing, however, is poor: buying a +6.7% gap with RSI approaching 70 is a chase. The better-quality setup is a pullback into the $560-$575 zone where the 20-, 50- and 200-day averages converge; a decisive break back below ~$550 would invalidate the breakout.

• Equity market levels and ETF flows: asset-based fees reached $249.1M in Q3 2026 (+24.9% YoY) and are directly levered to AUM and market values, making the S&P 500's level a bigger earnings driver than anything management controls.
• Interest rates: MSCI carries $6.72B of long-term debt against just $261M of cash; higher-for-longer rates raise refinancing costs on debt raised for buybacks and compress the premium multiple quality compounders command.
• Structural shift to passive and active ETFs: MSCI's own 2026 ETF Intelligence Survey found 71% of advisers planning to increase active ETF allocations - the single most durable tailwind behind AUM-linked revenue.
• Index methodology and regulation: the exclusion of crypto-treasury 'non-operating companies', the Indonesia Emerging Market-to-Standalone consultation and the Turkey index freeze show that rule changes can redirect client flows quickly.
• Currency and cross-border allocation: a large share of revenue is non-U.S., so dollar strength is a translation headwind and global asset-allocation decisions sway subscription growth independent of market levels.

• 2026-11-11 publication of the definitive non-operating-company exclusion list, effective after the 2026-11-30 close - hits crypto-treasury names like Strategy and Metaplanet and could shift index-linked flows.
• Resolution of the Indonesia market reclassification consultation and the status of the MSCI Turkey index freeze, both flagged in October 2026.
• Q4 2026 results on 2027-01-26: the $19.67 forward EPS estimate looks conservative against the $5.11 adjusted Q3 print, making upward revision a live positive catalyst.
• Continued ETF inflows and active-ETF adoption feeding the asset-based fee line, which grew 24.9% YoY last quarter.
• Capital return: $627.2M of buybacks completed through mid-October 2026 plus the declared $2.05 quarterly dividend.

• Asset-based fee sensitivity: ~28% of Q3 2026 revenue is tied to market levels. A 20% equity drawdown would hit the fee base and the multiple simultaneously - the classic double hit for this model.
• Leverage and negative equity: long-term debt rose from $4.51B (6/30/2025) to $6.72B (9/30/2026) to fund buybacks, pushing stockholders' equity to -$3.02B and net debt to ~$6.5B, or roughly 3.2x TTM EBITDA.
• Competitive fee compression in indexing from S&P Dow Jones, FTSE Russell, Bloomberg and in-house/direct-indexing solutions chasing the same passive dollar.
• ESG and index-methodology backlash: U.S. political and regulatory pushback on ESG ratings could pressure the ESG & Climate segment and add headline risk to methodology decisions.
• Client concentration among a handful of mega asset managers and ETF issuers; losing one large license or a shift toward custom indexes would be material to recurring revenue.
• Cash conversion has decelerated: TTM FCF grew 2.1% versus 12.3% revenue growth as capex and working capital absorbed operating leverage - if that persists, the FCF-based valuation case weakens.

Good business, fair-to-slightly-cheap stock. MSCI earns 56% operating margins on a subscription base with 95% retention, grew revenue 12.4% last quarter, and trades at ~31x forward EPS against a 46x five-year average - the direction is right. But ~$6.5B of net debt, negative book equity from debt-funded buybacks, and a fee stream levered to equity markets argue against paying up right after a +6.7% earnings pop. My ~$665 fair value implies roughly 10% upside, which is decent but not compelling; the mechanical Neutral is a fair description, and the setup gets materially more interesting on a pullback into the $560-$575 support zone.

I applied ~30x to FY2027E EPS of ~$22.20 (the $19.67 forward estimate grown ~13% on 12% revenue growth, TTM margin expansion of ~150bps and buyback accretion), a deliberate discount to the 5-year average P/E of 46.3x that reflects a slower growth era and ~$6.5B of net debt. A cross-check DCF on post-SBC FCF of ~$18.7/share at 10% growth, an 8.5% discount rate and 3% terminal growth lands near $605, and 28x EV/EBITDA on ~$2.0B TTM EBITDA lands near $685, so I weight to the upper-middle of that $605-$685 band at ~$665.